Company

Immunophotonics is a private biotechnology company that is developing a proprietary carbohydrate polymer (IP-001) for use after a common tumor ablation procedure to induce a systemic anti-tumor immune response. Immunophotonics has subsidiaries in Bern, Switzerland and Tianjin, China. We are a multidisciplinary team of highly experienced individuals committed to pioneering the future of cancer immunotherapy.

TEAM

Lu Alleruzzo  CEO

Lu Alleruzzo
CEO

Tomas Hode, Ph.D.  Chief Innovation Officer & President

Tomas Hode, Ph.D.
Chief Innovation Officer & President

Joseph Raker, Ph.D.  Senior VP of CMC

Joseph Raker, Ph.D.
Senior VP of CMC

Theresa Visarius, Ph.D.  VP Business Dev.

Theresa Visarius, Ph.D.
VP Business Dev.

 
Siu Kit Lam, Ph.D.  VP Science & Research

Siu Kit Lam, Ph.D.
VP Science & Research

Troy Jiao, MFE  VP Asian Business Dev.

Troy Jiao, MFE
VP Asian Business Dev.

Diane M. Beatty, Ph.D.  VP of Regulatory & Clinical Affairs

Diane M. Beatty, Ph.D.
VP of Regulatory & Clinical Affairs

Monica Croke, Ph.D.  Clinical Consultant

Monica Croke, Ph.D.
Clinical Consultant

 

Board

Bobby Sandage, Ph.D.  Chairman

Bobby Sandage, Ph.D.
Chairman

Charlie Bolten  Biogenerator

Charlie Bolten
Biogenerator

David Smoller, Ph.D.  Cultivation Capital

David Smoller, Ph.D.
Cultivation Capital

Robert Nordquist, Ph.D.  Inventor

Robert Nordquist, Ph.D.
Inventor

 
Wei Chen, Ph.D.  Inventor

Wei Chen, Ph.D.
Inventor

Tomas Hode, Ph.D.  Chief Innovation Officer

Tomas Hode, Ph.D.
Chief Innovation Officer

Lu Alleruzzo  CEO

Lu Alleruzzo
CEO

 

Advisors

Mark Naylor, M.D.  Clinical Development

Mark Naylor, M.D.
Clinical Development

Michael Hamblin, Ph.D.  Non-clinical Development

Michael Hamblin, Ph.D.
Non-clinical Development

Grant Williams, M.D.  Regulatory Strategy

Grant Williams, M.D.
Regulatory Strategy

Daniel Von Hoff, M.D.  Clinical Development

Daniel Von Hoff, M.D.
Clinical Development

 
Richard Levenson, M.D.  Clinical Development

Richard Levenson, M.D.
Clinical Development

John Weatherspoon  J.D./Ph.D. IP Protection

John Weatherspoon
J.D./Ph.D.
IP Protection

David W. Anderson, Ph.D.  Non-clinical Development

David W. Anderson, Ph.D.
Non-clinical Development